The rising demand for and widespread use of sterile injectable drug formulations is driven by the growth of biopharmaceuticals, enhanced bioavailability through bypassing the digestive system, and advancements in drug delivery technologies such as long-acting injectables -- all aligned with evolving patient needs.
However, manufacturing injectable formulations presents significant challenges, including:
- Complex formulation requirements
- Use of complex active pharmaceutical ingredients (APIs)
- The need for detailed characterization of intricate drug delivery and release systems
- Potential contamination introduced from manufacturing and packaging components
- Meeting regulatory expectations